100% agreed! It would be shorted to current price! It would need a perfect storm of approval and uplist at same time. Doing a R/S on the OTC would be an unmitigated disaster.
If a BO is in the works, the current share count is irrelevant. The valuation would be the same
To uplist we will need a 4B MC- will UK approval and or a partner get us there without a reverse split? What about Sunday if LL discusses combo treatments?in any event I think this was the plan when LP designed the series of PR’s in rapid succession post journal.